Finance

Lists
Why is 603983 down 6,11%?
Dive Deeper
603983:SHA
Guangdong Marubi Biotechnology Co Ltd
CN¥25,64
-6,11%
(-1,67) 1D
15 Okt., 15:00:01 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 603983...
Open
CN¥27,00
High
CN¥27,06
Low
CN¥25,49
Mkt. cap
11,57 mjd
Avg. vol.
4,76 m
Volume
3,69 m
Dividend
1,95%
Quarterly dividend
CN¥0,12
Ex-dividend date
16 Jul. 2026
P/E ratio
47,37
52-wk high
CN¥39,68
52-wk low
CN¥21,20
EPS
CN¥0,54
No. of employees
1 k
Open
CN¥27,00
High
CN¥27,06
Low
CN¥25,49
Mkt. cap
11,57 mjd
Avg. vol.
4,76 m
Volume
3,69 m
Dividend
1,95%
Quarterly dividend
CN¥0,12
Ex-dividend date
16 Jul. 2026
P/E ratio
47,37
52-wk high
CN¥39,68
52-wk low
CN¥21,20
EPS
CN¥0,54
No. of employees
1 k
News stories
From web sources and news partners
About Guangdong Marubi Biotechnology Co Ltd
CEO-
Employees1,38 k
Founded02 Apr. 2002
Headquarters-
SectorPersonal care products
Websitemarubi.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
681,19 m
1,01 mjd
881,29 m
781,79 m
Cost of goods sold
164,07 m
278,10 m
230,72 m
209,66 m
Cost of revenue
164,07 m
278,10 m
230,72 m
209,66 m
Research and development expenses
22,09 m
22,58 m
20,55 m
24,03 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
465,72 m
701,76 m
505,93 m
542,40 m
Operating expense
489,86 m
744,45 m
531,68 m
573,56 m
Total operating expenses
653,93 m
1,02 mjd
762,40 m
783,22 m
Operating income
27,26 m
-13,61 m
118,89 m
-1,43 m
Other non operating income
-812,89 k
-619,64 k
-182,86 k
127,50 k
EBT including unusual items
57,75 m
-2,79 m
123,23 m
59,61 m
EBT excluding unusual items
45,95 m
-1,29 m
123,81 m
62,37 m
Income tax expense
-2,86 m
-2,88 m
22,23 m
3,65 m
Effective tax rate
-4,96%
103,35%
18,04%
6,13%
Other operating expenses
2,86 m
20,49 m
5,81 m
6,55 m
Net income
58,15 m
3,35 m
101,02 m
54,45 m
Net profit margin
8,54%
0,33%
11,46%
6,96%
Earnings per share
-
-
-
-
Interest and investment income
19,60 m
13,50 m
7,79 m
63,49 m
Interest expense
-33,31 k
-592,98 k
-2,68 m
-
Net interest expenses
19,57 m
12,90 m
5,10 m
63,49 m
Depreciation and amortization charges
-
-
-
-
EBITDA
32,64 m
1,09 m
133,59 m
14,27 m
Gain or loss from assets sale
377,40 k
-377,40 k
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme